alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

                  United States Securities and Exchange Commission
                               Washington, D.C. 20549

                                    FORM 10-Q/A

(Mark One)

     x      Quarterly Report Pursuant to Section 13 or 15(d) of the Securities
---------   Exchange Act of 1934
                  FOR THE QUARTERLY PERIOD ENDED FEBRUARY 28, 1998

or


            Transition Report Pursuant to Section 13 of 15(d) of the Securities
---------   Exchange Act of 1934
                    For the transition period from ____ to ____


                          COMMISSION FILE NUMBER: 0-11769




                           CONAM REALTY INVESTORS 3 L.P.
                           -----------------------------
                                 formerly known as
                          HUTTON/CONAM REALTY INVESTORS 3
                          -------------------------------
                EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER




     California                                      13-3176625
     ----------                                      ----------
STATE OR OTHER JURISDICTION OF                    I.R.S. EMPLOYER
 INCORPORATION OR ORGANIZATION                   IDENTIFICATION NO.


1764 San Diego Avenue
San Diego, Ca. 92110  Attn. Robert J. Svatos                92110-1906
--------------------------------------------                ----------
ADDRESS OF PRINCIPAL EXECUTIVE OFFICES                       ZIP CODE

                                   (619)-297-6771
                                   --------------
               REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE







Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
                    Yes  x     No
                       -----     -----

<PAGE>


                                      SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                         CONAM PROPERTY SERVICES IV, LTD.
                         General Partner of ConAm Realty Investors 3 L.P.

                         BY:  CONTINENTAL AMERICAN DEVELOPMENT, INC.
                              GENERAL PARTNER


Date:  April 14, 1998         BY:/s/ DANIEL J. EPSTEIN
                                     -----------------
                                     Daniel J. Epstein
                                     Director, President, and Principal
                                     Executive Officer


Date:  April 14, 1998         BY:/s/ ROBERT J. SVATOS
                                     ----------------
                                     Robert J. Svatos
                                     Vice President and Director
I 

109TH CONGRESS 

1ST SESSION H. R. 1432 

To require the Secretary of the Treasury to redesign the $1 coin to 

commemorate Dr. Martin Luther King, Jr. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 17, 2005 

Mr. RANGEL introduced the following bill; which was referred to the 

Committee on Financial Services 

A BILL 

To require the Secretary of the Treasury to redesign the 

$1 coin to commemorate Dr. Martin Luther King, Jr. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE AND FINDINGS. 

4 (a) SHORT TITLE.—This Act may be cited as the 

5 ‘‘Dr. Martin Luther King, Jr., $1 Coin Act’’. 

6 (b) FINDINGS.—The Congress finds the following: 

7 (1) Dr. Martin Luther King, Jr. was a pre8 eminent spokesman for human civil rights in his 

9 time. 
2 

•HR 1432 IH 

1 (2) The work of Dr. King affected the lives of 

2 more Americans of all races and people around the 

3 world than any other American reform leader of the 

4 20th century. 

5 (3) Dr. King was one of America’s most erudite 

6 scholars and social and religious activists. 

7 (4) Dr. King, because of his lifelong achieve8 ments and moral vision, was a recipient in 1964 of 

9 the Nobel Peace Prize. 

10 (5) Dr. King mobilized leaders of all faiths, 

11 races, and creeds to support the passage of the his12 toric civil rights laws in the 1960s. 

13 (6) Dr. King inspired activists for human rights 

14 around the world by applying a philosophy of non15 violence. 

16 (7) Dr. King helped to mobilize the African17 American civil rights movement as a founder of the 

18 Southern Christian Leadership Conference. 

19 (8) Dr. King has been honored by the Nation 

20 with the designation of the third Monday in January 

21 as a national holiday in his name. 

22 (9) The largest collection of materials relating 

23 to Dr. King is in the Martin Luther King, Jr. Cen24 ter for Nonviolent Social Change in Atlanta, Geor25 gia. 
3 

•HR 1432 IH 

1 SEC. 2. REDESIGN OF $1 COIN TO COMMEMORATE DR. MAR2 TIN LUTHER KING, JR. 

3 Section 5112(d)(1) of title 31, United States Code, 

4 is amended— 

5 (1) by striking the 6th sentence and inserting 

6 the following: ‘‘The obverse side of the dollar shall 

7 have the likeness of Dr. Martin Luther King, Jr. 

8 The reverse side of the dollar shall have a design 

9 emblematic of Dr. Martin Luther King, Jr.’’; and 

10 (2) in the 4th sentence, by striking ‘‘dollar, half 

11 dollar, and quarter dollar’’ and inserting ‘‘half dollar 

12 and quarter dollar’’. 

Æ
Exhibit 32(a)

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

Pursuant to Section 906
of the Sarbanes-Oxley Act of 2002 and in connection with the Annual Report on Form 10-K of Zep Inc. (the Corporation) for the year ended August 31, 2008, as filed with the Securities and Exchange Commission on the date hereof (the
Report), the undersigned, the Chairman, President, and Chief Executive Officer of the Corporation, certifies that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------------------



|                                               
|-----------------------------------------------
|/s/ John K. Morgan                             
|John K. Morgan                                 
|Chairman, President and Chief Executive Officer
|November 7, 2008                               

[A signed original of this written statement required by Section 906 has been provided to Zep Inc. and will be retained
by Zep Inc. and furnished to the Securities and Exchange Commission or its staff upon request.]
THE THIRTEENTH COURT OF APPEALS

13-21-00135-CV

OCTAVIO AGUILERA; THE SCHUMACHER GROUP OF TEXAS, INC.; VHS 

HARLINGEN HOSPITAL COMPANY, LLC D/B/A VALLEY BAPTIST MEDICAL 

CENTER-HARLINGEN; ADRIAN ALANIZ; KRISTEN WHITE; GEORGE 

HUDDLESTON, IV, M.D.; AND WILLIAM TAW, M.D.

v.

ELIAZAR COSTILLA, INDIVIDUALLY AND AS THE REPRESENTATIVE OF THE 

ESTATE OF KRISTY RENEE COSTILLA, DECEASED, AND AS NEXT FRIEND OF 

A.J.C. AND C.K.C., MINORS; MELINDA RODRIGUEZ LEAL; AND CAMILO TREVINO

On Appeal from the

197th District Court of Cameron County, Texas

Trial Court Cause No. 2020-DCL-04542-C

JUDGMENT

THE THIRTEENTH COURT OF APPEALS, having considered this cause on 

appeal, concludes the judgment of the trial court should be reversed and the cause 

remanded to the trial court. The Court orders the judgment of the trial court and 

REVERSED AND REMANDED for further proceedings consistent with its opinion. Costs 

of the appeal are adjudged against appellees.

We further order this decision certified below for observance.

March 30, 2023
### D ISTRICT 

### C OURT 

### O F 

### A PPEAL 

### O F 

### T HE 

### S TATE 

### O F 

### F LORIDA F OURTH D ISTRICT

TONY GARCIA , Appellant,

v.

STATE OF FLORIDA , Appellee

.

No. 4D 20 2 4

- 0140

[ May 9, 2024 ]

Appeal of order denying rule 3.8 5 0 motion from the Circuit Court for the Fifteenth Judicial Circuit, Palm Beach County ; Scott Ira Suskauer

, Judge; L.T. Case No. 502014CF012520AXXX

.
Tony Garcia

, Lake Worth , pro se

.
No appearance required for appellee

.

P ER C URI A M

.
Affirmed

.

W ARNER , M AY and C IKLIN , JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
Exhibit 10.7.1


                                 Amendment No. 2
                                     to the
           Citizens Communications Company 2000 Equity Incentive Plan

                            (Effective June 30, 2003)

                            -------------------------



1. The first  sentence of Section  5(a) of the Citizens  Communications  Company
2000  Equity  Incentive  Plan (the  "Plan")  is  hereby  amended  and  restated,
effective June 30, 2003, to read as follows:

     "With respect to the Options and SARs,  the  Committee  shall (i) authorize
     the granting of incentive stock options,  nonqualified stock options,  SARs
     or a combination of incentive stock options, nonqualified stock options and
     SARs;  (ii)  determine the number of shares of Stock subject to each Option
     or the number of shares of Stock that shall be used to determine  the value
     of a SAR; (iii) determine  whether such Stock shall be Restricted Stock or,
     with respect to nonqualified stock options,  Deferred Stock; (iv) determine
     the time or times  when  and the  manner  in  which  each  Option  shall be
     exercisable  and the duration of the  exercise  period;  and (v)  determine
     whether or not all or part of each Option may be  canceled by the  exercise
     of  a  SAR;  provided,  however,  that  the  aggregate  Fair  Market  Value
     (determined as of the date of Option is granted) of the Stock (disregarding
     any restrictions in the case of Restricted Stock) for which incentive stock
     options granted to any Eligible Individual under this Plan may first become
     exercisable in any calendar year shall not exceed  $100,000,  and provided,
     further,  that, effective June 30, 2003, no non-employee  director shall be
     permitted to receive his annual retainer fees in the form of Options."

2. Except as specifically  provided herein,  the Plan shall remain in full force
and effect.
[Federal Register Volume 60, Number 89 (Tuesday, May 9, 1995)]
[Notices]
[Page 24619]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-11289]



-----------------------------------------------------------------------


DEPARTMENT OF DEFENSE

Meeting of the Commission on Roles and Missions of the Armed 
Forces

AGENCY: Department of Defense, Commission on Roles and Missions of the 
Armed Forces.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given of a forthcoming meeting of the 
Commission on Roles and Missions of the Armed Forces.
    The Commission is charged with providing an independent review of 
the roles and missions of the armed services to Congress, the Secretary 
of Defense and the Chairman of the Joint Chiefs of Staff. The year-long 
review will identify changes that can be made to improve military 
effectiveness and eliminate unnecessary duplication among the services. 
The purpose of this meeting is to discuss some of the specific roles 
and missions issues that are being developed for consideration by the 
Commission. Material to be discussed will consist of both classified 
and unclassified information in a format that makes it impractical to 
separate the two.
    In accordance with section 10(d) of the Federal Advisory Committee 
Act, Public Law 92-453, as amended (5 U.S.C. App II), it has been 
determined that this Commission on Roles and Missions meeting concerns 
matters listed in 5 U.S.C. 552b(c)(1), and that, accordingly, this 
meeting will be closed to the public.

DATES: May 17, 1995.

    Dated: May 3, 1995.
Patricia L. Toppings,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 95-11289 Filed 5-8-95; 8:45 am]
BILLING CODE 5000-04-M
UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF INDIANA

SOUTH BEND DIVISION

UNITED STATES OF AMERICA )

)

v. ) Case No. 3:13-CR-054 JD

)

DECARLO KNIGHTEN )

ORDER

No objections have been filed to the magistrate judge’s findings and recommendation upon

a plea of guilty issued on July 15, 2013 [DE 22]. Accordingly, the court now ADOPTS those

findings and recommendations, ACCEPTS defendant Decarlo Knighten’s plea of guilty, ACCEPTS

the plea agreement, and FINDS the defendant guilty of Count 4 of the Indictment, in violation of 18 

U.S.C. § 922(g)(1).

SO ORDERED.

ENTERED: August 2, 2013 

 /s/ JON E. DEGUILIO 

Judge

United States District Court
Paul L. ASHBAUGH, petitioner, v. CORPORATION OF BOLIVAR, WEST VIRGINIA, et al.

No. 12-874.

Supreme Court of the United States

April 29, 2013.

Petition for rehearing denied.
UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF INDIANA

FORT WAYNE DIVISION

UNITED STATES OF AMERICA )

)

v. ) CAUSE NO. 1:13-CR-23

)

JUAN SANDOVAL )

FINDINGS AND RECOMMENDATION

OF THE MAGISTRATE JUDGE

UPON A PLEA OF GUILTY

TO: THE HONORABLE THERESA L. SPRINGMANN, JUDGE, 

UNITED STATES DISTRICT COURT

Upon Defendant’s request to enter a plea of guilty pursuant to Rule 11 of the Federal Rules

of Criminal Procedure, this matter came on for hearing before U.S. Magistrate Roger B. Cosbey,

on September 19, 2013, with the written consents of the defendant, counsel for the defendant, and

counsel for the United States of America.

The hearing on defendant’s plea of guilty was in full compliance with Rule 11, Federal

Rules of Criminal Procedure, before the Magistrate Judge in open court and on the record.

In consideration of that hearing and the statements made by the defendant under oath on

the record and in the presence of counsel, the remarks of the Assistant United States Attorney and

of counsel for defendant,

I FIND as follows:

(1) that defendant understands the nature of the charges against him to which the plea is

offered;

(2) that the defendant understands his right to trial by jury, to persist in his plea of not

guilty, to the assistance of counsel at trial, to confront and cross-examine adverse witnesses, and
his right against compelled self-incrimination;

(3) that the defendant understands what the maximum possible sentence is, including the

effect of the supervised release term, and defendant understands that the Sentencing Guidelines

apply and that the Court may depart from those guidelines under some circumstances;

(4) that the plea of guilty by the defendant has been knowingly and voluntarily made and

is not the result of force or threats or of promises apart from the plea agreement between the

parties;

(5) that defendant is competent to plead guilty;

(6) that the defendant understands that his answers may later be used against him in a

prosecution for perjury or false statement;

(7) that there is a factual basis for the defendant’s plea; and further,

I RECOMMEND that the Court accept the defendant’s plea of guilty and that the

Defendant be adjudged guilty of the offenses charged in Counts 2 and 3 of the four-count

Indictment, and have sentence imposed. A Presentence Report has been ordered. Should this

Report and Recommendation be accepted and the Defendant adjudged guilty, sentencing will be

scheduled before Judge Theresa L. Springmann by separate order and notice. Objections to the

Findings and Recommendation are waived unless filed and served within fourteen (14) days. 28

U.S.C. § 636(b)(1)(B).

DATED this 19th day of September, 2013.

/s/ Roger B. Cosbey 

Roger B. Cosbey

United States Magistrate Judge

2
Joseph M. JACKSON, petitioner, v. Tracy McCALLUM, Warden.

No. 12-9116.

Supreme Court of the United States

May 13, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Tenth Circuit denied.
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

RASHAWN J. WILLIAMS,

Petitioner

:

:

:

:

:

:

:

:

:

:

:

No. 374 MAL 2022

Petition for Allowance of Appeal 

from the Order of the Superior Court

ORDER

PER CURIAM

AND NOW, this 7th day of February, 2023, the Petition for Allowance of Appeal is 

DENIED.
### THE THIRTEENTH COURT OF APPEALS

13

- 16

- 00152

- CR

WALLY SALDANA v. THE STATE OF TEXAS
On Appeal from the 156th District Court of Bee County , Texas Trial Cause No. B

- 11

- 2183

- 0

- CR

- B

JUDGMENT THE THIRTEENTH COURT OF APPEALS, having considered this cause on appeal, concludes that the judgment of the trial court should be AFFIRMED . The Court orders the judgment of the trial court AFFIRMED

. We further order this decision certified below for observance. October 6, 2016
The ESTATE OF E. Wayne HAGE, et al., petitioners, v. UNITED STATES.

No. 12-918.

Supreme Court of the United States

June 17, 2013.

*2825Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit denied.
EXHIBIT 10.11(f)  


August 15,
2003 


Mr. Robert
Urban

Vice President, Technical Operations

Cephalon, Inc.

145 Brandywine Parkway

West Chester, PA 19380 



	Re:
	Amendment
No. 5 to Toll Manufacturing and Packaging Agreement 




        This
letter is to confirm our agreement to amend the Toll Manufacturing and Packaging Agreement dated as of August 24, 1999, as amended by Amendment No.1 dated July 3,
2001, by Amendment No. 2 dated October 9, 2001, by Amendment No. 3 dated June 21, 2002, and by Amendment No. 4 dated April 28, 2003 (collectively, the
"Agreement"), between Cephalon, Inc. ("Cephalon") and DSM Pharmaceuticals, Inc. ("DSM"). All terms not otherwise defined herein are used as defined in the Agreement. 


        The
purpose of this Amendment No. 5 is to update the Tolling Fees for Product listed in existing Schedule E to include Provigil Aqueous Formulation Tablets. The Agreement
is hereby amended as follows: 




Existing
Schedule E of the Agreement relating to Tolling Fees shall be deleted in its entirety and replaced with the attached revised Schedule E. 





        If
you agree with Amendment No. 5 as stated herein, please sign both copies of this amendment in the space below and return one signed original to me. 


Sincerely,




	 
	 
	 	 

	

/s/  TERENCE S. NOVAK      
 Terence S. Novak

Senior Vice President Commercial Operations	
 	

 
	

Amendment No. 5 accepted and agreed:	
 	

 
	

CEPHALON, INC.	
 	

 
	

By:	

/s/  ROBERT J. URBAN      
	
 	

 
	

Name: Robert J. Urban

Title: Vice President, Manufacturing & Engineering







 
Schedule E

Tolling Fees  


        Cephalon shall pay DSM the following amounts in consideration of the formulations and packaging services rendered hereunder: 



	 
	 	Current Formulation

(Compressil Formula)
	 	New Formulation

(Aqueous Formula)

	Provigil 100mg, bulk tablets	 	[**]	 	[**]
	Provigil 100mg, 100 count bottles	 	[**]	 	[**]






	 
	 	Current Formulation

(Compressil Formula)
	 	New Formulation

(Aqueous Formula)

	Provigil 200mg, bulk tablets	 	[**]	 	[**]
	Provigil 200mg, 100 count bottles	 	[**]	 	[**]






        The
above prices do not include the cost of Modafinil or Magnerium Silicate (Compressil), but do include packaging material costs. These prices are based on batches being campaigned once
per quarter. 


        Annual
price increases will be invoked as per Section IV of the Toll Manufacturing and Packaging Agreement (dated August 24, 1999) (the "Agreement"). The review of the
annual pricing is based on the Producer Price Index (PPI) for the prior year Pharmaceutical Preparations, series code
PCU-2834# as published by the Bureau of Labor Statistics of the U.S. Department of Labor. 


	**
	Portions
of this exhibit have been omitted and filed separately pursuant to an application for confidential treatment filed with the Securities and Exchange Commission pursuant to Rule
24b-2 under the Securities Exchange Act of 1934, as amended. 


A-1
Daniel David DYDZAK, petitioner, v. Arnold SCHWARZENEGGER, et al.

No. 13-5330.

Supreme Court of the United States

Nov. 12, 2013.

Motion of petitioner for reconsideration of order denying leave to proceed *in forma pauperis* denied.
Exhibit 31.1
 CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
      (a)
    
    Designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being
prepared;(b)
    
    Designed such internal control over financial reporting, or caused such internal control
over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting
principles;(c)
    
    Evaluated the effectiveness of the registrants disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such evaluation;
and(d)
    
    Disclosed in this report any change in the registrants internal control over financial
reporting that occurred during the registrants most recent fiscal quarter that has
materially affected, or is reasonably likely to materially affect, the registrants internal
control over financial reporting; and
  (a)
    
    All significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the registrants ability to record, process, summarize and report financial information; and(b)
    
    Any fraud, whether or not material, that involves management or other employees who have
a significant role in the registrants internal control over financial reporting.
 /s/ Kambiz HooshmandKambiz HooshmandPresident and Chief Executive Officer
Arthur GALLAGHER, petitioner v. CITY OF CLAYTON, MISSOURI, et al.

No. 12-1122.

Supreme Court of the United States

May 13, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Eighth Circuit denied.
Rodney Edward THOMPSON, petitioner, v. UNITED STATES.

No. 12-9223.

Supreme Court of the United States

June 17, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.